Before revision:  We identified four compounds (the atypical antipsychotic Ziprasidone, the antihistamine Buclizine, the antiviral Beclabuvir and the antimalaric Artefenomel) as capable of  lowering ACE2 expression in Vero cells in a dose-dependent fashion.
After revision:  We identified four compounds (the atypical antipsychotic Ziprasidone, the antihistamine Buclizine, the antiviral Beclabuvir and the antimalaric Artefenomel) as capable of dose-dependently lowering ACE2 expression in Vero cells in a dose-dependent fashion.